Therma Bright Inc.THRM.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · thermabright.com
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical applications. The company's products include InterceptCS for cold sore prevention, Benepod for contrast therapy pain relief, Venowave for vascular compression therapy, and TherOZap for insect bite relief. The company is headquartered in Toronto, Ontario.
Key ratios
FCF / Sales
-244.1%TTM
2025
-194.8%2024
-16821.7%2023
-103566.7%
ROA
-45.4%TTM
2025
-64.5%2024
-29.1%2023
-74.5%
ROE
-65911.1%TTM
2024
-358.1%2023
-269.9%
Revenue growth
134.1%TTM
2025
1150.7%2024
192.6%2023
-98.5%
Recent news
Therma Bright Announces up to $420,000 Non-Brokered Private Placement
Therma Bright Inc. Completes Debt Settlements
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
Track THRM.V in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer